Top-Rated StocksTop-RatedNYSE:PHR Phreesia (PHR) Stock Price, News & Analysis $18.53 -0.02 (-0.11%) (As of 11/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Phreesia Stock (NYSE:PHR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Phreesia alerts:Sign Up Key Stats Today's Range$17.78▼$18.5750-Day Range$18.04▼$24.6852-Week Range$14.55▼$29.16Volume650,881 shsAverage Volume442,032 shsMarket Capitalization$1.07 billionP/E RatioN/ADividend YieldN/APrice Target$29.42Consensus RatingModerate Buy Company OverviewPhreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.Read More… Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Phreesia Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks92nd Percentile Overall ScorePHR MarketRank™: Phreesia scored higher than 92% of companies evaluated by MarketBeat, and ranked 107th out of 963 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingModerate Buy Consensus RatingPhreesia has received a consensus rating of Moderate Buy. The company's average rating score is 2.92, and is based on 11 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoveragePhreesia has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Phreesia's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Phreesia are expected to grow in the coming year, from ($1.23) to ($0.58) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Phreesia is -10.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Phreesia is -10.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPhreesia has a P/B Ratio of 4.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Phreesia's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.09% of the outstanding shares of Phreesia have been sold short.Short Interest Ratio / Days to CoverPhreesia has a short interest ratio ("days to cover") of 7.8.Change versus previous monthShort interest in Phreesia has recently increased by 11.79%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPhreesia does not currently pay a dividend.Dividend GrowthPhreesia does not have a long track record of dividend growth. Sustainability and ESG4.2 / 5Environmental Score-0.60 Percentage of Shares Shorted5.09% of the outstanding shares of Phreesia have been sold short.Short Interest Ratio / Days to CoverPhreesia has a short interest ratio ("days to cover") of 7.8.Change versus previous monthShort interest in Phreesia has recently increased by 11.79%, indicating that investor sentiment is decreasing significantly. News and Social Media3.4 / 5News Sentiment1.19 News SentimentPhreesia has a news sentiment score of 1.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Phreesia this week, compared to 4 articles on an average week.Search Interest1 people have searched for PHR on MarketBeat in the last 30 days. MarketBeat Follows1 people have added Phreesia to their MarketBeat watchlist in the last 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Phreesia insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,035,226.00 in company stock.Percentage Held by InsidersOnly 5.80% of the stock of Phreesia is held by insiders.Percentage Held by Institutions92.10% of the stock of Phreesia is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Phreesia's insider trading history. Receive PHR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Phreesia and its competitors with MarketBeat's FREE daily newsletter. Email Address PHR Stock News HeadlinesPhreesia, Inc. (NYSE:PHR) SVP Sells $22,539.00 in StockOctober 23, 2024 | insidertrades.comPhreesia Sets Release Date for Fiscal Third Quarter 2025 ResultsNovember 1, 2024 | businesswire.comThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…November 21, 2024 | WealthPress (Ad)Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable IntegrationOctober 28, 2024 | businesswire.comPhreesia CEO Chaim Indig sells $64,946 in common stockOctober 19, 2024 | investing.comEarnings Preview For HealthStreamOctober 19, 2024 | benzinga.comAn Overview of HealthStream's EarningsOctober 19, 2024 | benzinga.comIs Phreesia, Inc. (NYSE:PHR) The Top Stock With Improving Technical Ratings According To Piper Sandler?October 12, 2024 | msn.comSee More Headlines PHR Stock Analysis - Frequently Asked Questions How have PHR shares performed this year? Phreesia's stock was trading at $23.15 at the beginning of 2024. Since then, PHR stock has decreased by 20.0% and is now trading at $18.53. View the best growth stocks for 2024 here. How were Phreesia's earnings last quarter? Phreesia, Inc. (NYSE:PHR) posted its earnings results on Wednesday, September, 4th. The company reported ($0.31) EPS for the quarter, topping the consensus estimate of ($0.37) by $0.06. The business had revenue of $102.12 million for the quarter, compared to analyst estimates of $101.76 million. Phreesia had a negative trailing twelve-month return on equity of 39.34% and a negative net margin of 25.73%. When did Phreesia IPO? Phreesia (PHR) raised $127 million in an initial public offering on Thursday, July 18th 2019. The company issued 7,800,000 shares at $15.00-$17.62 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray acted as the underwriters for the IPO. Who are Phreesia's major shareholders? Top institutional shareholders of Phreesia include FMR LLC (11.59%), Champlain Investment Partners LLC (4.33%), UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (2.66%) and State Street Corp (2.30%). Insiders that own company stock include Chaim Indig, Evan Roberts, David Linetsky, Randy Rasmussen, Allison C Hoffman, Amy Beth Vanduyn, Balaji Gandhi, Michael J Davidoff, Janet Gunzburg, Yvonne Hui and Gillian Munson. View institutional ownership trends. How do I buy shares of Phreesia? Shares of PHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Phreesia own? Based on aggregate information from My MarketBeat watchlists, some other companies that Phreesia investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), CrowdStrike (CRWD), Arista Networks (ANET) and Palo Alto Networks (PANW). Company Calendar Last Earnings9/04/2024Today11/21/2024Next Earnings (Confirmed)12/09/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Business services, not elsewhere classified Sub-IndustryBusiness Services Current SymbolNYSE:PHR CUSIPN/A CIK1412408 Webwww.phreesia.com Phone(888) 654-7473Fax646-607-1776Employees1,438Year FoundedN/APrice Target and Rating Average Stock Price Target$29.42 High Stock Price Target$34.00 Low Stock Price Target$23.00 Potential Upside/Downside+58.8%Consensus RatingModerate Buy Rating Score (0-4)2.92 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)($1.80) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-136,880,000.00 Net Margins-25.73% Pretax Margin-25.25% Return on Equity-39.34% Return on Assets-27.13% Debt Debt-to-Equity Ratio0.03 Current Ratio1.77 Quick Ratio1.77 Sales & Book Value Annual Sales$356.30 million Price / Sales3.00 Cash FlowN/A Price / Cash FlowN/A Book Value$4.52 per share Price / Book4.10Miscellaneous Outstanding Shares57,770,000Free Float54,422,000Market Cap$1.07 billion OptionableOptionable Beta0.94 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report This page (NYSE:PHR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phreesia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phreesia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.